Mizuho lowered the firm’s price target on Charles River (CRL) to $175 from $215 and keeps a Neutral rating on the shares. The firm reduced estimates following the company’s “mixed” Q4 report. It cites Charles River’s slower organic growth profile in 2026, lower free cash flow in 2026 than expected, and a lower trading multiple given concerns about AI for the industry for the target cut.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRL:
- Buy Rating on Charles River Labs: Attractive Entry Point as AI Fears Overhang Fundamentals and Multiple Expansion Potential
- Charles River price target lowered to $193 from $231 at Baird
- Charles River price target lowered to $200 from $260 at Evercore ISI
- Charles River price target lowered to $200 from $215 at Barclays
- Strategic Review at Charles River Laboratories Raises Deal Uncertainty, Execution Risks, and Shareholder Value Concerns